Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Software Development
    Feb 14th, 2025
  • $18,500,000
    Series A

    2 Investors

    Financial Services
    Feb 14th, 2025
  • $30,000,000
    Unknown

    1 Investors

    Hospital & Health Care
    Feb 14th, 2025
$218.72M Raised in 20 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Rapport Therapeutics

start up
United States - Boston, Massachusetts
  • 08/03/2023
  • Series A
  • $100,000,000

Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.


Related People

Abraham (Abe) CeesayFounder

Abraham (Abe) Ceesay United States - Greater Boston

N/A